Related Experiment Video
Updated: Jul 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Antihypertensive medications and their effects on lipid metabolism
Mrunalini Deshmukh1, Ho Won Lee, Samy I McFarlane
1Department of Medicine, Box 50, State University of New York Health Science Center at Brooklyn, Kings County Hospital Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA. mrunalini.deshmukh@downstate.edu
Insights
Managing hypertension and hyperlipidemia is crucial for cardiovascular health. Some blood pressure drugs impact lipid metabolism, necessitating careful medication selection for optimal patient outcomes.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Hypertension and hyperlipidemia share common mechanisms like insulin resistance and endothelial dysfunction.
- Managing both conditions is vital for reducing cardiovascular risk.
- Certain antihypertensive medications may negatively affect lipid and glucose metabolism.
Purpose of the Study:
- To review the relationship between hypertension and hyperlipidemia.
- To discuss the metabolic side effects of common antihypertensive drugs.
- To explore the impact of different antihypertensive classes on lipid profiles.
Main Methods:
- Literature review of studies on hypertension, hyperlipidemia, and antihypertensive medications.
- Analysis of the effects of various drug classes on lipid metabolism.
- Examination of clinical implications for cardiovascular risk reduction.
Main Results:
- Beta-blockers and thiazide diuretics can have adverse metabolic effects but reduce cardiovascular risk.
- Calcium channel blockers, ACE inhibitors, and alpha-blockers generally have neutral or favorable effects on lipid profiles.
- The choice of antihypertensive medication can influence lipid parameters and overall cardiovascular outcomes.
Conclusions:
- Careful consideration of antihypertensive medication's effects on lipid metabolism is essential.
- Tailoring treatment based on individual patient profiles can optimize cardiovascular risk management.
- Further research into medications with favorable metabolic profiles is warranted.
Abstract:
Hypertension and hyperlipidemia are interrelated and share common pathophysiologic mechanisms, such as insulin resistance and endothelial dysfunction. Accumulating evidence shows that it is important to regulate hypertension and hyperlipidemia to reduce cardiovascular risk. However, medications such as beta-blockers and thiazide diuretics, which are widely used for blood pressure regulation, are known to have several metabolic side effects. Despite deleterious effects on glucose metabolism and lipid metabolism, these medications have been proven to reduce cardiovascular risk. On the other hand, calcium channel blockers, angiotensin-converting enzyme inhibitors, and alpha-blockers have either no effect or favorable effects on the lipid profile. This review outlines the need to control hypertension, options for several antihypertensive medications, their differing effects on lipid metabolism, and the clinical implications of their effects on lipid parameters.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Thiazide-Class Diuretics